Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 20 of 137 Clinical Trials

Clinical Research Trial

ENABLE

REal world experieNce with BRIUMVI® (ublituximAB-xiiy)  treated patients:  a Longitudinal rEgistry study (ENABLE)

Doctor(s) Running This Study
Gary W. Clauser, MD
Clinical Research Trial

C – Beyond AT-01B-007

Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects with Chronic Hepatitis C

Doctor(s) Running This Study
Orlando J. Penaloza, MD
Clinical Research Trial

NRG-GY037 Cervical Cancer

A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-GY037 Cervical Cancer

A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-CC014

RADIATION THERAPY FOR HIGH-RISK ASYMPTOMATIC BONE METASTASES: A PRAGMATIC MULTICENTER RANDOMIZED PHASE 3 CLINICAL TRIAL (PREEMPT)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

LYL314-101 Lymphoma

A PHASE 1/2 MULTI-CENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF LYL314, A CD19/CD20 DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PARTICIPANTS WITH AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

Doctor(s) Running This Study
Usama Gergis, MD, MBA
Clinical Research Trial

LYL314-101 Lymphoma

A PHASE 1/2 MULTI-CENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF LYL314, A CD19/CD20 DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PARTICIPANTS WITH AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

Doctor(s) Running This Study
Usama Gergis, MD, MBA
Clinical Research Trial

EMN30 Multiple Myeloma

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation”

Doctor(s) Running This Study
Bradley W. Lash, MD